Yuichiro Doki Selected Research

Interferons

1/2023	Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer.
1/2022	Fecal Stream Diversion Changes Intestinal Environment, Modulates Mucosal Barrier, and Attenuates Inflammatory Cells in Crohn's Disease.
3/2015	Combination therapy with S-1 and interferon-α in hepatocellular carcinoma patients with lung metastasis.
8/2014	Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line.
11/2013	[Long-term survival of a patient with multiple advanced hepatocellular carcinomas with portal vein tumor thrombus].
11/2013	[Long-term survival of a patient with hepatocellular carcinoma with portal vein tumor thrombus treated with interferon-α and 5-fluorouracil combination therapy].
1/2013	Combined IFN-α and 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombus.
12/2012	Suppression of signal transducers and activators of transcription 1 in hepatocellular carcinoma is associated with tumor progression.
11/2012	[A case of advanced hepatocellular carcinoma with inferior vena cava tumor thrombus and multiple intrahepatic metastases treated successfully by transcatheter arterial chemoembolization and radical hepatectomy].
11/2011	miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichiro Doki Research Topics

Disease

484	Neoplasms (Cancer) 06/2024 - 12/2000
157	Esophageal Neoplasms (Esophageal Cancer) 02/2024 - 03/2002
136	Stomach Neoplasms (Stomach Cancer) 05/2024 - 12/2000
121	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 05/2009
109	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2004
88	Esophageal Squamous Cell Carcinoma 05/2024 - 10/2004
68	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 05/2002
66	Adenocarcinoma 05/2024 - 12/2000
51	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 07/2003
38	Rectal Neoplasms (Rectal Cancer) 02/2024 - 11/2010
36	Lymphatic Metastasis 04/2024 - 12/2000
31	Colonic Neoplasms (Colon Cancer) 05/2022 - 01/2004
25	Inflammation (Inflammations) 04/2024 - 09/2011
23	Body Weight (Weight, Body) 05/2024 - 01/2006
23	Thrombosis (Thrombus) 08/2023 - 09/2004
20	Hemorrhage 12/2023 - 05/2002
19	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2023 - 12/2013
18	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 03/2002
16	Wounds and Injuries (Trauma) 12/2022 - 11/2012
15	Infections 04/2024 - 01/2004
14	Carcinogenesis 04/2024 - 03/2002
14	Cholangiocarcinoma 09/2023 - 11/2008
13	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 08/2023 - 08/2006
13	Carcinoma (Carcinomatosis) 01/2023 - 01/2006
13	Hypoxia (Hypoxemia) 01/2023 - 05/2005
12	Pancreatic Fistula (Pancreatic Fistulas) 08/2023 - 01/2011
11	Pain (Aches) 05/2023 - 07/2011
11	Weight Loss (Weight Reduction) 01/2023 - 07/2010
10	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2023 - 05/2013
9	Crohn Disease (Crohn's Disease) 11/2023 - 11/2015
9	Diarrhea 10/2023 - 01/2013
9	Surgical Wound Infection 01/2022 - 11/2012
8	Liver Neoplasms (Liver Cancer) 05/2024 - 09/2010
8	Pathologic Constriction (Stenosis) 08/2023 - 11/2009
8	Disease Progression 01/2023 - 01/2013
8	Vomiting 01/2021 - 03/2012
8	Nausea 01/2021 - 11/2010

Drug/Important Bio-Agent (IBA)

66	Proteins (Proteins, Gene)FDA Link 03/2024 - 03/2002
48	Fluorouracil (Carac)FDA LinkGeneric 07/2023 - 09/2002
43	MicroRNAs (MicroRNA)IBA 08/2023 - 05/2010
37	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2009
36	Indicators and Reagents (Reagents)IBA 02/2024 - 07/2003
36	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 09/2002
34	Gemcitabine FDA Link 05/2024 - 11/2009
34	Messenger RNA (mRNA)IBA 04/2024 - 10/2004
32	AntigensIBA 03/2024 - 05/2007
29	Docetaxel (Taxotere)FDA Link 01/2024 - 02/2006
27	EnzymesIBA 04/2024 - 06/2012
26	InterferonsIBA 01/2023 - 08/2006
22	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 05/2014
22	GhrelinIBA 06/2022 - 01/2006
17	NivolumabIBA 05/2024 - 01/2017
16	Tumor Biomarkers (Tumor Markers)IBA 03/2024 - 07/2010
16	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2010
14	Transcription Factors (Transcription Factor)IBA 08/2023 - 01/2011
13	Imatinib Mesylate (Gleevec)FDA Link 05/2023 - 12/2013
13	C-Reactive ProteinIBA 01/2023 - 04/2006
13	VaccinesIBA 11/2022 - 10/2004
12	Capecitabine (Xeloda)FDA Link 01/2023 - 05/2014
11	Small Interfering RNA (siRNA)IBA 03/2024 - 05/2009
11	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 03/2007
10	CytokinesIBA 05/2024 - 09/2012
10	AntibodiesIBA 03/2024 - 05/2007
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 03/2002
10	Bevacizumab (Avastin)FDA Link 04/2022 - 01/2013
10	Leucovorin (Folinic Acid)FDA Link 01/2021 - 09/2002
10	Cancer VaccinesIBA 10/2018 - 04/2007
9	CarbohydratesIBA 03/2024 - 05/2012
9	Therapeutic UsesIBA 09/2023 - 09/2010
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 07/2009
9	Peptides (Polypeptides)IBA 10/2022 - 05/2007
8	Interleukin-6 (Interleukin 6)IBA 02/2024 - 05/2013
8	Immune Checkpoint InhibitorsIBA 01/2023 - 09/2018
8	CarbonIBA 07/2021 - 07/2015
8	EpitopesIBA 01/2017 - 04/2007
8	Interferon-alpha (Interferon Alfa)IBA 12/2013 - 08/2006
7	Carcinoembryonic AntigenIBA 03/2024 - 03/2014

Therapy/Procedure

181	Therapeutics 03/2024 - 06/2005
180	Drug Therapy (Chemotherapy) 05/2024 - 09/2002
110	Neoadjuvant Therapy 05/2024 - 09/2002
89	Gastrectomy 04/2024 - 02/2005
81	Esophagectomy 02/2024 - 03/2004
45	Chemoradiotherapy 02/2024 - 04/2006
43	Hepatectomy 05/2024 - 05/2002
40	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 03/2002
38	Radiotherapy 02/2024 - 03/2005
30	Adjuvant Chemotherapy 04/2024 - 11/2008
24	Pancreatectomy 02/2024 - 07/2003
21	Liver Transplantation 02/2024 - 11/2008
20	Colectomy 05/2024 - 04/2014
15	Pancreaticoduodenectomy 08/2023 - 09/2004
13	Immunotherapy 02/2024 - 06/2009
13	Operative Surgical Procedures 06/2023 - 11/2009
11	Transplantation 08/2023 - 11/2008
11	Laparotomy 01/2022 - 03/2004
10	Combined Modality Therapy 05/2022 - 10/2003
9	Length of Stay 12/2019 - 03/2012
8	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 11/2009
7	Aftercare (After-Treatment) 02/2024 - 02/2014
7	Induction Chemotherapy 02/2024 - 10/2009